NCT00152230View on ClinicalTrials.gov

A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-CC)

PHASE3CompletedINTERVENTIONAL
Enrollment

900

Participants

Timeline

Start Date

October 31, 1996

Primary Completion Date

March 31, 2006

Study Completion Date

February 29, 2008

Conditions
Colorectal Cancer
Interventions
DRUG

UFT (uracil, tegafur)

to receive oral uracil-tegafur 400 mg square meter for one year

PROCEDURE

Surgery alone

Standardized mesorectal excision with selective lateral pelvic lymphadenectomy of stage III rectal cancer.

Trial Locations (1)

Unknown

National Cancer Center Hospital East, 6-5-1, Kashiwanoha, Kashiwa, Chiba

All Listed Sponsors
lead

Taiho Pharmaceutical Co., Ltd.

INDUSTRY

NCT00152230 - A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-CC) | Biotech Hunter | Biotech Hunter